Akebia Therapeutics Inc. (AKBA) slipped -13.04% or -1.05 to $7.0. It is nearly 2.56 million shares traded, which is 180.86% compare to the average total volume 1.41 million. The market cap of AKBA is $819.86 million. The year to date change is 25.75%. The 52 week price range is from $5.2 to $11.6. Price of AKBA have changed -7.79% during last week. It have changed 4.82% over last month, 38.79% over last 3 months, -5.41% over last 6 months and -18.36% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKBA is 7.05. It is 0.71% above current price. The stock faces resistance at 50-day moving averages. The 200-day Moving Averages for AKBA is 8.10. It is 15.71% above current price. The 52-week High is 11.6. It is 65.71% from the current price. The 52-week Low is 5.2. It is -25.71% from current price.
There are some statistics of AKBA. It is has market cap $819.86 million. The share outstanding is 117.12 million. The average volume is 1.41 million. The percent of top 15 Institution holding is 86.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKBA is -38.12%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKBA is -21.35%.